AI Clinical Support Platform Developed for Psychiatry
A new tool aims to help clinicians integrate patient history and speech into mental health treatment plans.
Updated on Oct. 4, 2026 in Mental Health
Live Poll
Do you trust artificial intelligence to help your doctor decide on your mental health treatment?
MedLink Global has developed Comentra, an AI-based clinical decision support platform designed to assist psychiatrists in updating patient diagnoses and treatment plans. The system utilizes patient history and ambient speech to generate diagnostic questions and evidence-based clinical options.
Why it matters
As psychiatric care becomes increasingly complex, this platform attempts to provide a more comprehensive view of patient data to improve clinical decision-making. The technology is designed to bridge information gaps, though it restricts output when available data is deemed insufficient.
A 2025 review identified 84 AI-enabled clinical decision support tools for mental health, yet only 7 held regulatory clearance and only 5 had peer-reviewed validation studies. This indicates that most current tools in this sector lack independent scientific verification.
The players
MedLink Global
A health technology company that develops AI-based clinical decision support platforms for psychiatric practice.
Christoph Correll
The chief medical officer of MedLink Global who oversees the clinical development of psychiatric support tools.
The details
The Comentra system functions by synthesizing ambient speech and clinical history to identify gaps in a patient's diagnostic profile. It proactively generates follow-up questions to fill these gaps before suggesting treatment pathways that align with established clinical guidelines. To maintain safety, the software is programmed to refrain from offering recommendations if the input data does not reach a specific threshold of completeness.
Timeline
A review of available mental health AI tools was conducted in 2025.
MedLink Global website information was accessed on October 3, 2026.
This report was published on October 4, 2026.
Health Landscape
The introduction of Comentra occurs as the psychiatric field grapples with a high volume of digital tools that lack rigorous scientific validation. While developers seek to improve care, the current landscape is defined by the findings of the 2025 review of AI-enabled mental health tools, which identified significant gaps in clinical oversight.
If your psychiatrist mentions the use of AI tools during your sessions, you may want to ask how the software supports, rather than replaces, their clinical judgment. These tools are intended for use as decision aids, so it is important to discuss how your care plan is ultimately decided by your physician.
The takeaway
AI tools in psychiatry are increasingly common, but most lack independent validation of their clinical benefits. Always ensure that any technological support used in your treatment is a supplement to—not a replacement for—the ongoing clinical conversation you have with your psychiatrist.
Further reading
For more on the current state of digital tools in behavioral care, visit our Mental Health section.
More information
Review additional details regarding the technology on the MedLink Global company information page.
Live Poll
Do you trust artificial intelligence to help your doctor decide on your mental health treatment?
